Due to the broad-spectrum of its therapeutic implications, MAGL has drawn increased attention as a promising drug target [9] and the therapeutic potential of selective MAGL inhibitors has been highlighted in animal models of inflammation, pain, anxiety and other neuroinflammatory diseases [10,11]. This evidence concerns the gene MGLL and Anxiety.